{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T17:14:20Z","timestamp":1783444460963,"version":"3.54.6"},"posted":{"date-parts":[[2026,1,12]]},"group-title":"In Review","reference-count":41,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,12,18]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  <italic>Rationale:<\/italic>\n                  Fatal opioid overdoses involving synthetic opioids have increased &gt;10-fold over the past 8 years. Fentanyl, a potent synthetic opioid acting at the mu-opioid receptor (MOR), has largely replaced heroin as the predominant illicit opioid available. Various analogs have been synthesized from the fentanyl scaffold, including 2-furanylfentanyl, one of the most trafficked analogs from 2019 to 2024. Despite its prevalence, the\n                  <italic>in vivo<\/italic>\n                  effects of furanylfentanyl are not well characterized, especially regarding respiratory depression.\n                  <italic>Objectives:<\/italic>\n                  To characterize furanylfentanyl relative to fentanyl\n                  <italic>in vitro<\/italic>\n                  and compare the effects of both drugs in mouse models of antinociception and respiratory depression.\n                  <italic>Methods:<\/italic>\n                  The affinity and potency of fentanyl and furanylfentanyl were determined in CHO cells overexpressing MOR. Male and female mice were administered (\n                  <italic>i.p.<\/italic>\n                  ) fentanyl or furanylfentanyl prior to measuring antinociception (warm-water tail withdrawal), respiration (whole-body plethysmography), or oxygen saturation (pulse oximetry).\n                  <italic>Results:<\/italic>\n                  Furanylfentanyl behaves as a partial agonist\n                  <italic>in vitro<\/italic>\n                  relative to fentanyl and morphine but with similar affinity and potency at MOR. In mice, fentanyl and furanylfentanyl produced similar effects on breathing parameters (including rate and inspiration time) that were greater than those induced by morphine, yet only fentanyl caused a drastic, long-lasting depletion of blood oxygen saturation. The discrepancy between effects on breathing and oxygen saturation may be explained by a greater number of apneas induced by fentanyl.\n                  <italic>Conclusions:<\/italic>\n                  These results highlight the complexity of fentanyl-induced respiratory depression and indicate that recreational use of 2-furanylfentanyl in humans may pose a greater risk of overdose than morphine but lesser than fentanyl.\n                <\/p>","DOI":"10.21203\/rs.3.rs-8398857\/v1","type":"posted-content","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T14:58:38Z","timestamp":1768229918000},"source":"Crossref","is-referenced-by-count":0,"title":["Fentanyl decreases blood oxygen more than furanylfentanyl despite similar effects on breathing"],"prefix":"10.21203","author":[{"given":"Catherine","family":"Demery","sequence":"first","affiliation":[{"name":"University of Michigan Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sierra C.","family":"Moore","sequence":"additional","affiliation":[{"name":"University of Michigan Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey E.","family":"Kochan","sequence":"additional","affiliation":[{"name":"University of Michigan Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengchu","family":"Li","sequence":"additional","affiliation":[{"name":"University of Michigan Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D.","family":"Prince","sequence":"additional","affiliation":[{"name":"University of Michigan Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin M.","family":"Clements","sequence":"additional","affiliation":[{"name":"University of Michigan Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongqi","family":"Chen","sequence":"additional","affiliation":[{"name":"University of Michigan College of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica R.","family":"Whitaker-Fornek","sequence":"additional","affiliation":[{"name":"University of Michigan Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica S.","family":"Levitt","sequence":"additional","affiliation":[{"name":"University of Michigan Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica P.","family":"Anand","sequence":"additional","affiliation":[{"name":"University of Michigan Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Traynor","sequence":"additional","affiliation":[{"name":"University of Michigan Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","volume-title":"Provisional drug overdose death counts","author":"Ahmad FB","year":"2025","unstructured":"Ahmad FB, Cisewski JA, Rossen LM, Sutton P (2025) Provisional drug overdose death counts. National Center for Health Statistics"},{"issue":"15","key":"ref2","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1021\/acschemneuro.4c00203","article-title":"Structure-Activity Relationships of the Fentanyl Scaffold: Identification of Antagonists as Potential Opioid Overdose Reversal Agents","volume":"15","author":"Anand JP","year":"2024","unstructured":"Anand JP, Moore SC, Dixon EE, Perrien Naccarato CM, West JL, Delong LJ, Burgess E, Twarozynski JJ, Traynor JR (2024) Structure-Activity Relationships of the Fentanyl Scaffold: Identification of Antagonists as Potential Opioid Overdose Reversal Agents. ACS Chem Neurosci 15(15):2830\u20132841","journal-title":"ACS Chem Neurosci"},{"issue":"5","key":"ref3","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2471\/BLT.17.020517","article-title":"Curbing prescription opioid dependency","volume":"95","author":"Anderson T","year":"2017","unstructured":"Anderson T (2017) Curbing prescription opioid dependency. Bull World Health Organ 95(5):318\u2013319","journal-title":"Bull World Health Organ"},{"issue":"7","key":"ref4","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/bph.15580","article-title":"Understanding and countering opioid-induced respiratory depression","volume":"180","author":"Bateman JT","year":"2023","unstructured":"Bateman JT, Saunders SE, Levitt ES (2023) Understanding and countering opioid-induced respiratory depression. Br J Pharmacol 180(7):813\u2013828","journal-title":"Br J Pharmacol"},{"key":"ref5","author":"Bilel S","year":"2022","unstructured":"Bilel S, Azevedo Neto J, Arfe R, Tirri M, Gaudio RM, Fantinati A, Bernardi T, Boccuto F, Marchetti B, Corli G, Serpelloni G, De-Giorgio F, Malfacini D, Trapella C, Calo G, Marti M (2022) In vitro and in vivo pharmaco-dynamic study of the novel fentanyl derivatives: Acrylfentanyl, Ocfentanyl and Furanylfentanyl. Neuropharmacology 209: 109020"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1277248","DOI":"10.3389\/fphar.2023.1277248","article-title":"Comparison of the effects of fentanyls and other mu opioid receptor agonists on the electrical activity of respiratory muscles in the rat","volume":"14","author":"Cavallo D","year":"2023","unstructured":"Cavallo D, Kelly E, Henderson G, Abdala Sheikh AP (2023) Comparison of the effects of fentanyls and other mu opioid receptor agonists on the electrical activity of respiratory muscles in the rat. Front Pharmacol 14:1277248","journal-title":"Front Pharmacol"},{"issue":"9","key":"ref7","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1007\/s00213-025-06790-2","article-title":"Assessment of abuse potential of furanylfentanyl and tetrahydrofuranylfentanyl","volume":"242","author":"Chen Y","year":"2025","unstructured":"Chen Y, Lai M, Li X, Qiao Y, Xu D, Fu D, Di B, Xu P (2025) Assessment of abuse potential of furanylfentanyl and tetrahydrofuranylfentanyl. Psychopharmacology 242(9):2123\u20132133","journal-title":"Psychopharmacology"},{"issue":"23","key":"ref8","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng Y","year":"1973","unstructured":"Cheng Y, Prusoff WH (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22(23):3099\u20133108","journal-title":"Biochem Pharmacol"},{"issue":"18","key":"ref9","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1056\/NEJMc1505541","article-title":"Shifting Patterns of Prescription Opioid and Heroin Abuse in the United States","volume":"373","author":"Cicero TJ","year":"2015","unstructured":"Cicero TJ, Ellis MS, Harney J (2015) Shifting Patterns of Prescription Opioid and Heroin Abuse in the United States. N Engl J Med 373(18):1789\u20131790","journal-title":"N Engl J Med"},{"key":"ref10","author":"Commission USS","year":"2021","unstructured":"Commission USS (2021) Quick Facts: Fentanyl Analogue Trafficking Offenses, Fiscal Year 2020"},{"key":"ref11","author":"Commission USS","year":"2022","unstructured":"Commission USS (2022) Quick Facts: Fentanyl Analogue Trafficking Offenses, Fiscal Year 2021"},{"key":"ref12","author":"Commission USS","year":"2023","unstructured":"Commission USS (2023) Quick Facts: Fentanyl Analogue Trafficking Offenses, Fiscal Year 2022"},{"key":"ref13","author":"Commission USS","year":"2024","unstructured":"Commission USS (2024) Quick Facts: Fentanyl Analogue Trafficking Offenses, Fiscal Year 2023"},{"key":"ref14","author":"Commission USS","year":"2025","unstructured":"Commission USS (2025) Quick Facts: Fentanyl Analogue Trafficking Offenses, Fiscal Year 2024"},{"key":"ref15","author":"Committee NRCU","year":"2011","unstructured":"Committee NRCU (2011) Guide for the Care and Use of Laboratory Animals. Guide for the Care and Use of Laboratory Animals. Washington (DC)"},{"key":"ref16","author":"Daniulaityte R","year":"2019","unstructured":"Daniulaityte R, Juhascik MP, Strayer KE, Sizemore IE, Zatreh M, Nahhas RW, Harshbarger KE, Antonides HM, Martins SS, Carlson RG (2019) Trends in fentanyl and fentanyl analogue-related overdose deaths - Montgomery County, Ohio, 2015\u20132017. Drug Alcohol Depend 198: 116\u2013120"},{"issue":"7","key":"ref17","doi-asserted-by":"crossref","first-page":"103616","DOI":"10.1016\/j.jpet.2025.103616","article-title":"Xylazine exacerbates fentanyl-induced respiratory depression and bradycardia","volume":"392","author":"Demery C","year":"2025","unstructured":"Demery C, Moore SC, Levitt ES, Anand JP, Traynor JR (2025) Xylazine exacerbates fentanyl-induced respiratory depression and bradycardia. J Pharmacol Exp Ther 392(7):103616","journal-title":"J Pharmacol Exp Ther"},{"key":"ref18","author":"Demetrius L","year":"2005","unstructured":"Demetrius L (2005) Of mice and men. When it comes to studying ageing and the means to slow it down, mice are not just small humans. EMBO Rep 6 Spec No(Suppl 1): S39-44"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"114293","DOI":"10.1016\/j.bcp.2020.114293","article-title":"Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptors","volume":"182","author":"Eshleman AJ","year":"2020","unstructured":"Eshleman AJ, Nagarajan S, Wolfrum KM, Reed JF, Nilsen A, Torralva R, Janowsky A (2020) Affinity, potency, efficacy, selectivity, and molecular modeling of substituted fentanyls at opioid receptors. Biochem Pharmacol 182:114293","journal-title":"Biochem Pharmacol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"110562","DOI":"10.1016\/j.neuropharm.2025.110562","article-title":"Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption","volume":"278","author":"Gannon BM","year":"2025","unstructured":"Gannon BM, Shepard ME, Pressley JM, Shaw HE, Wolf KJ, Avram M, Moran JH, Fantegrossi WE (2025) Effects of orally self-administered furanyl fentanyl and acryl fentanyl in mice: antinociception, dependence and withdrawal, and defense of consumption. Neuropharmacology 278:110562","journal-title":"Neuropharmacology"},{"issue":"3","key":"ref21","first-page":"242","article-title":"Postmortem and Toxicological Findings in a Series of Furanylfentanyl-Related Deaths","volume":"41","author":"Guerrieri D","year":"2017","unstructured":"Guerrieri D, Rapp E, Roman M, Druid H, Kronstrand R (2017) Postmortem and Toxicological Findings in a Series of Furanylfentanyl-Related Deaths. J Anal Toxicol 41(3):242\u2013249","journal-title":"J Anal Toxicol"},{"issue":"4","key":"ref22","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3109\/15563650.2016.1139715","article-title":"Intoxications involving the fentanyl analogs acetylfentanyl, 4-methoxybutyrfentanyl and furanylfentanyl: results from the Swedish STRIDA project","volume":"54","author":"Helander A","year":"2016","unstructured":"Helander A, Backberg M, Beck O (2016) Intoxications involving the fentanyl analogs acetylfentanyl, 4-methoxybutyrfentanyl and furanylfentanyl: results from the Swedish STRIDA project. Clin Toxicol (Phila) 54(4):324\u2013332","journal-title":"Clin Toxicol (Phila)"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/bph.14860","article-title":"Fentanyl depression of respiration: Comparison with heroin and morphine","volume":"177","author":"Hill R","year":"2020","unstructured":"Hill R, Santhakumar R, Dewey W, Kelly E, Henderson G (2020) Fentanyl depression of respiration: Comparison with heroin and morphine. Br J Pharmacol 177(2):254\u2013266","journal-title":"Br J Pharmacol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neuropharm.2019.02.008","article-title":"Respiratory depression and brain hypoxia induced by opioid drugs: Morphine, oxycodone, heroin, and fentanyl","volume":"151","author":"Kiyatkin EA","year":"2019","unstructured":"Kiyatkin EA (2019) Respiratory depression and brain hypoxia induced by opioid drugs: Morphine, oxycodone, heroin, and fentanyl. Neuropharmacology 151:219\u2013226","journal-title":"Neuropharmacology"},{"issue":"7","key":"ref25","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.lfs.2005.05.062","article-title":"Reversal of morphine, methadone and heroin induced effects in mice by naloxone methiodide","volume":"78","author":"Lewanowitsch T","year":"2006","unstructured":"Lewanowitsch T, Miller JH, Irvine RJ (2006) Reversal of morphine, methadone and heroin induced effects in mice by naloxone methiodide. Life Sci 78(7):682\u2013688","journal-title":"Life Sci"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1124\/jpet.122.001476","article-title":"Heroin- and Fentanyl-Induced Respiratory Depression in a Rat Plethysmography Model: Potency, Tolerance, and Sex Differences","volume":"385","author":"Marchette RCN","year":"2023","unstructured":"Marchette RCN, Carlson ER, Frye EV, Hastings LE, Vendruscolo JCM, Mejias-Torres G, Lewis SJ, Hampson A, Volkow ND, Vendruscolo LF, Koob GF (2023) Heroin- and Fentanyl-Induced Respiratory Depression in a Rat Plethysmography Model: Potency, Tolerance, and Sex Differences. J Pharmacol Exp Ther 385(2):117\u2013134","journal-title":"J Pharmacol Exp Ther"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/add.14474","article-title":"Illicit fentanyls in the opioid street market: desired or","volume":"114","author":"Mars SG","year":"2019","unstructured":"Mars SG, Rosenblum D, Ciccarone D (2019) Illicit fentanyls in the opioid street market: desired or. imposed? Addict 114(5):774\u2013780","journal-title":"imposed? Addict"},{"key":"ref28","volume-title":"Furanylfentanyl: another fentanyl analogue, another hazard for public health","author":"Nektaria Misailidi I","year":"2017","unstructured":"Nektaria Misailidi I, Papoutsis P, Nikolaou M, Katselou C, Spiliopoulou, Athanaselis S (2017) Furanylfentanyl: another fentanyl analogue, another hazard for public health. Forensic Toxicology"},{"issue":"10","key":"ref29","doi-asserted-by":"crossref","first-page":"271","DOI":"10.15585\/mmwr.mm6910a4","article-title":"Notes from the Field: Opioid-Involved Overdose Deaths with Fentanyl or Fentanyl Analogs Detected \u2013\u200928 States and the District of Columbia, July 2016-December 2018","volume":"69","author":"O'Donnell J","year":"2020","unstructured":"O'Donnell J, Gladden RM, Goldberger BA, Mattson CL, Kariisa M (2020) Notes from the Field: Opioid-Involved Overdose Deaths with Fentanyl or Fentanyl Analogs Detected \u2013\u200928 States and the District of Columbia, July 2016-December 2018. MMWR Morb Mortal Wkly Rep 69(10):271\u2013273","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref30","first-page":"110603","volume":"279","author":"Obeng S","year":"2025","unstructured":"Obeng S, Urquhart KR, Fukuda S, Pallares VLC, McMahon LR, Fantegrossi WE, Hiranita T (2025) vitro vivo Pharmacol Charact fentanyl analogs Neuropharmacol 279:110603","journal-title":"vitro vivo Pharmacol Charact fentanyl analogs Neuropharmacol"},{"issue":"1","key":"ref31","first-page":"170","article-title":"Mouse models of human disease: An evolutionary perspective","volume":"2016","author":"Perlman RL","year":"2016","unstructured":"Perlman RL (2016) Mouse models of human disease: An evolutionary perspective. Evol Med Public Health 2016(1):170\u2013176","journal-title":"Evol Med Public Health"},{"key":"ref32","article-title":"Peripheral opioid receptor antagonism alleviates fentanyl-induced cardiorespiratory depression and is devoid of aversive behavior. Elife 13","author":"Ruyle BC","year":"2025","unstructured":"Ruyle BC, Masud S, Kesaraju R, Tahirkheli M, Modh J, Roth CG, Angulo-Lopera S, Lintz T, Higginbotham JA, Massaly N, Moron JA (2025) Peripheral opioid receptor antagonism alleviates fentanyl-induced cardiorespiratory depression and is devoid of aversive behavior. Elife 13"},{"issue":"2","key":"ref33","volume":"11","author":"Seyedabadi M","year":"2021","unstructured":"Seyedabadi M, Gharghabi M, Gurevich EV, Gurevich VV (2021) Receptor-Arrestin Interactions: GPCR Perspective Biomolecules 11(2)","journal-title":"Receptor-Arrestin Interactions: GPCR Perspective Biomolecules"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/sj.bjp.0707598","article-title":"Activities of mixed NOP and mu-opioid receptor ligands","volume":"153","author":"Spagnolo B","year":"2008","unstructured":"Spagnolo B, Calo G, Polgar WE, Jiang F, Olsen CM, Berzetei-Gurske I, Khroyan TV, Husbands SM, Lewis JW, Toll L, Zaveri NT (2008) Activities of mixed NOP and mu-opioid receptor ligands. Br J Pharmacol 153(3):609\u2013619","journal-title":"Br J Pharmacol"},{"key":"ref35","volume-title":"Fentanyl and Fentanyl Analogues: Federal Trends and Trafficking Patterns","author":"Tennyson KM","year":"2021","unstructured":"Tennyson KM, Ray CS, Maass KT (2021) Fentanyl and Fentanyl Analogues: Federal Trends and Trafficking Patterns. U. S. S. Commission"},{"issue":"4","key":"ref36","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0026-895X(25)08634-1","article-title":"Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells","volume":"47","author":"Traynor JR","year":"1995","unstructured":"Traynor JR, Nahorski SR (1995) Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells. Mol Pharmacol 47(4):848\u2013854","journal-title":"Mol Pharmacol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.drugalcdep.2018.06.020","article-title":"Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting","volume":"190","author":"Tupper KW","year":"2018","unstructured":"Tupper KW, McCrae K, Garber I, Lysyshyn M, Wood E (2018) Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting. Drug Alcohol Depend 190:242\u2013245","journal-title":"Drug Alcohol Depend"},{"key":"ref38","author":"Drug Enforcement Administration US","year":"2025","unstructured":"Drug Enforcement Administration US (2025) D. C. D. NFLIS-Drug Data Query System"},{"key":"ref39","author":"analysis","unstructured":"analysis National Forensic Laboratory Information System"},{"issue":"2","key":"ref40","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4103\/atm.ATM_215_19","article-title":"The correlation between oxygen saturation indices and the standard obstructive sleep apnea severity","volume":"15","author":"Wali SO","year":"2020","unstructured":"Wali SO, Abaalkhail B, AlQassas I, Alhejaili F, Spence DW, Pandi-Perumal SR (2020) The correlation between oxygen saturation indices and the standard obstructive sleep apnea severity. Ann Thorac Med 15(2):70\u201375","journal-title":"Ann Thorac Med"},{"issue":"11","key":"ref41","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s11517-010-0674-2","article-title":"Sleep apnea monitoring and diagnosis based on pulse oximetry and tracheal sound signals","volume":"48","author":"Yadollahi A","year":"2010","unstructured":"Yadollahi A, Giannouli E, Moussavi Z (2010) Sleep apnea monitoring and diagnosis based on pulse oximetry and tracheal sound signals. Med Biol Eng Comput 48(11):1087\u20131097","journal-title":"Med Biol Eng Comput"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8398857\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8398857\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:13:53Z","timestamp":1783440833000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8398857\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":41,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-8398857\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1007\/s00213-026-07092-x","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2026,1,12]]},"subtype":"preprint"}}